EUVIMEDEUVIMED entdecken
Open Access

Multiplexed selectivity screening of anti-GPCR antibodies

Leo Dahl iD, Ilana B Kotliar iD, Annika Bendes iD, Tea Dodig-Crnković iD, Samuel Fromm iD, Arne Elofsson iD, Mathias Uhlén iD, Thomas P Sakmar iD, Jochen M Schwenk iD

Science Advances · 05.05.2023 · 9 (18)

DOI: 10.1126/sciadv.adf9297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 05.05.2023. Verfasst von Leo Dahl und 8 weiteren Autor:innen. Beteiligte Einrichtung: Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, 171 65 Solna, …. Hauptthemen laut MEDLINE: Signal Transduction, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

G protein–coupled receptors (GPCRs) control critical cellular signaling pathways. Therapeutic agents including anti-GPCR antibodies (Abs) are being developed to modulate GPCR function. However, validating the selectivity of anti-GPCR Abs is challenging because of sequence similarities among individual receptors within GPCR subfamilies. To address this challenge, we developed a multiplexed immunoassay to test >400 anti-GPCR Abs from the Human Protein Atlas targeting a customized library of 215 expressed and solubilized GPCRs representing all GPCR subfamilies. We found that ~61% of Abs tested were selective for their intended target, ~11% bound off-target, and ~28% did not bind to any GPCR. Antigens of on-target Abs were, on average, significantly longer, more disordered, and less likely to be buried in the interior of the GPCR protein than the other Abs. These results provide important insights into the immunogenicity of GPCR epitopes and form a basis for designing therapeutic Abs and for detecting pathological auto-Abs against GPCRs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionReceptors, G-Protein-CoupledHumansAntigensEpitopes

Substanzen

Receptors, G-Protein-CoupledAntigensEpitopes

Autor:innen und Institutionen

  • Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, 171 65 Solna, Sweden.
  • Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, 1230 York Ave., New York, NY 10065, USA.
  • Tri-Institutional PhD Program in Chemical Biology, New York, NY 10065, USA.
  • Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, 171 65 Solna, Sweden.
  • Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, 171 64 Solna, Sweden.

ORCID-Profile: Leo Dahl, Ilana B Kotliar, Annika Bendes, Tea Dodig-Crnković, Samuel Fromm, Arne Elofsson, Mathias Uhlén, Thomas P Sakmar, Jochen M Schwenk

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Dahl, L., Kotliar, I. B., Bendes, A., Dodig-Crnković, T., Fromm, S., Elofsson, A., Uhlén, M., Sakmar, T. P., & Schwenk, J. M. (2023). Multiplexed selectivity screening of anti-GPCR antibodies. Science Advances, 9(18). https://doi.org/10.1126/sciadv.adf9297

Vancouver

Dahl L, Kotliar IB, Bendes A, Dodig-Crnković T, Fromm S, Elofsson A, et al. Multiplexed selectivity screening of anti-GPCR antibodies. Science Advances. 2023;9(18). doi:10.1126/sciadv.adf9297

BibTeX
@article{Dahl2023,
  author = {Dahl, Leo and Kotliar, Ilana B and Bendes, Annika and Dodig-Crnković, Tea and Fromm, Samuel and Elofsson, Arne and Uhlén, Mathias and Sakmar, Thomas P and Schwenk, Jochen M},
  title = {Multiplexed selectivity screening of anti-GPCR antibodies},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {18},
  doi = {10.1126/sciadv.adf9297}
}
Kostenlos starten →